{
    "summary": "This bill, the Producing Incentives for Long-term production of Lifesaving Supply of medicine Act (PILLS Act), aims to incentivize the domestic production of generic drugs and biosimilars. It establishes a production credit based on value added, with increased percentages for certain components and a domestic content bonus. It also introduces an investment credit for qualified facilities. Both credits can be utilized via elective payments and transfers. The bill includes definitions, outlines phase-out provisions, and specifies effective dates for the introduced incentives.",
    "tags": [
        "Healthcare",
        "Economic recovery",
        "Tax reform",
        "Job creation",
        "Healthcare access",
        "Economic stimulus"
    ],
    "category": "Healthcare & Public Health"
}